Advancing Malic Acid Production of Aspergillus oryzae : Combined Process Optimization and Application of Various Substrates
Biotechnology and Bioengineering · 2026-06 · 123 (6) · 1634-1647
DOI: 10.1002/bit.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 14.04.2026. Verfasst von Lukas Hartmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Karlsruhe Institute of Technology, Karlsruhe, Germany. Hauptthemen laut MEDLINE: Aspergillus oryzae, Malates, Culture Media. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Ernährung und Landwirtschaft.
Abstract (Originalsprache)
In light of climate change and growing resource scarcity, microbial production of organic acids offers a sustainable alternative to fossil‐based chemical synthesis. In this study, malic acid production by Aspergillus oryzae was optimized through cultivation temperature adjustment and biotin supplementation, while organic acid formation from various carbon sources was systematically characterized. The process conditions applied during substrate screening, including pH control using Na 2 CO 3 and NaOH, Zn 2+ supplementation and hypoxia, were based on previously established strategies to stimulate malic acid production. Cultivation at 35°C increased respiratory activity compared to 32°C, resulting in an average productivity of 0.17 g L −1 h −1 . Biotin supplementation enhanced productivity by 20% and increased the carbon yield, defined as the proportion of consumed carbon recovered in malic acid, by 5%. Under optimized cultivation conditions, the highest malic acid productivity was achieved in cultivation with glucose as substrate and Na 2 CO 3 as pH‐neutralizing agent, reaching 57.57 g L −1 malic acid with a yield of 0.66 g g −1 and an overall productivity of 0.24 g L −1 h −1 , while fructose and glycerol resulted in substantially lower productivities. Furthermore, we demonstrate the ability to perform carbon balancing even in the presence of carbonate‐based neutralizing agents. This is achieved by quantifying and subtracting the CO 2 generated during neutralization reactions from the total emissions, enabling precise determination of microbial CO 2 production and calculation of carbon yields. By systematically combining optimization strategies reported in previous studies, this work achieves productivity and carbon efficiency exceeding those of the individual approaches reported so far.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Karlsruhe Institute of Technology, Karlsruhe, Germany.
- Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.
- University of Applied Sciences Kaiserslautern, Pirmasens, Germany.
ORCID-Profile: Lukas Hartmann, Dirk Holtmann, Katrin Ochsenreither
Förderung
- Bundesministerium für Ernährung und Landwirtschaft
Zitieren
APA
Hartmann, L., Neumann, A., Holtmann, D., Vater, B., Hahn, T., Zibek, S., & Ochsenreither, K. (2026). Advancing Malic Acid Production of Aspergillus oryzae : Combined Process Optimization and Application of Various Substrates. Biotechnology and Bioengineering, 123(6), 1634-1647. https://doi.org/10.1002/bit.70201
Vancouver
Hartmann L, Neumann A, Holtmann D, Vater B, Hahn T, Zibek S, et al. Advancing Malic Acid Production of Aspergillus oryzae : Combined Process Optimization and Application of Various Substrates. Biotechnology and Bioengineering. 2026;123(6):1634-1647. doi:10.1002/bit.70201
BibTeX
@article{Hartmann2026,
author = {Hartmann, Lukas and Neumann, Anke and Holtmann, Dirk and Vater, Björn and Hahn, Thomas and Zibek, Susanne and Ochsenreither, Katrin},
title = {Advancing Malic Acid Production of Aspergillus oryzae : Combined Process Optimization and Application of Various Substrates},
journal = {Biotechnology and Bioengineering},
year = {2026},
volume = {123},
number = {6},
pages = {1634--1647},
doi = {10.1002/bit.70201}
}
EUVIMED